Medpace Holdings, Inc. Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP

Kedudukan dalam Saham #1221
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Harga Saham
$655.91
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$18.31B
Perubahan (1 hari)
5.38%
Perubahan (1 tahun)
19.97%
Negara
US
Perdagangan Medpace Holdings, Inc. (MEDP)

Kategori

Healthcare
Sejarah harga saham bagi Medpace Holdings, Inc. (MEDP)
Harga penutupan tertinggi: $615.44 pada 2026-10-01

Harga penutupan terendah: $28.30 pada 2016-08-01
Sejarah harga saham Medpace Holdings, Inc. dari 2016 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -4.71%
2025 64.84%
2024 15.73%
2023 41.41%
2022 -2.02%
2021 53.55%
2020 71.69%
2019 48.38%
2018 52.53%
2017 0.13%
2016 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$694.53 22.45%
US
$234.00 7.29%
US
$416.01 121.26%
US
$21.16 49.45%
CN
$177.93 21.98%
US